Bunge (BG) Q2 EPS Beats by 20%

Bunge Global reported Q2 2025 non-GAAP EPS of $1.31 and GAAP revenue of $12.77 billion, both surpassing analyst estimates, yet adjusted EPS declined 24.3% and adjusted EBIT fell 27.8% year-over-year amid industry margin pressures. The quarter, marked by the transformative Viterra acquisition and the sale of its U.S. corn milling business, saw GAAP net income rise to $354 million, though strategic activity and working capital needs led to negative cash from operations of $1.36 billion and total debt climbing to $11.3 billion. Bunge reaffirmed its full-year 2025 adjusted EPS guidance at $7.75, excluding Viterra, with future integration and margin stabilization being key areas for investors to monitor.

Analysis

Bunge Global (BG) reported paradoxical second-quarter 2025 results, beating analyst estimates with non-GAAP EPS of $1.31 and revenue of $12.77 billion, while simultaneously revealing significant year-over-year operational deterioration. Core profitability metrics declined sharply, with adjusted EPS falling 24.3% and adjusted total EBIT dropping 27.8%, reflecting severe margin pressure and lower volumes across its primary business lines. The Agribusiness segment's adjusted EBIT fell 27.6%, and the Refined & Specialty Oils segment saw a more pronounced 39.9% EBIT decline, which management attributed partly to uncertainty in U.S. biofuels policy. The company's balance sheet showed considerable strain, with cash from operations turning to a negative $1.36 billion for the first six months and total debt climbing to $11.3 billion. This quarter was highly transitional, marked by the finalized sale of the U.S. corn milling business and the closure of the transformative Viterra acquisition after quarter-end, meaning its financial impact is not yet reflected. Bunge reaffirmed its full-year 2025 adjusted EPS guidance at $7.75, but this outlook excludes Viterra, creating uncertainty until combined guidance is issued.

Key Decisions for Investors

• Investors should treat current results as largely backward-looking and focus on the forthcoming combined guidance, as the successful integration of Viterra now represents the primary driver of the investment thesis.
• The sharp increase in total debt to $11.3 billion and negative operating cash flow warrant heightened scrutiny; monitor the company's ability to manage its leveraged balance sheet and restore cash generation, particularly during a costly and complex merger.
• Given the downward revision to the Refined & Specialty Oils outlook, investors should closely track margin stabilization in that segment and monitor external risks, including shifts in U.S. biofuels policy and the implementation of EU deforestation regulations.
• It may be prudent to hold off on significant new capital allocation until the post-merger financial profile is clarified, as the reaffirmed $7.75 EPS guidance does not account for the new, larger entity's earnings power or risk profile.